The Kennel Club Genetics Centre at the Animal Health Trust has identified a genetic mutation which causes progressive retinal atrophy (PRA) in Golden Retrievers, and developed a DNA test to identify carriers.

PRA is a retinal disease which causes loss of vision and leads to blindness. PRA cannot be treated - the most successful way to combat the inherited condition is to identify dogs that carry the mutation and develop informed breeding strategies.

The new DNA test has been developed following the identification of the mutation which causes the most common form of PRA among Golden Retrievers in Europe - known as GR_PRA1. The mutation which causes a second form of PRA is still to be identified.

Cathryn Mellersh, Head of Canine Genetics at the AHT, said: "Our research shows that this mutation is present in the UK Golden Retriever population, so it's likely that several hundred new carriers are being born each year and that Golden Retrievers are invariably going blind as a result.

"This new DNA test will enable breeders to learn whether their dogs are carriers of the mutation. This, in turn, will enable them to make better informed breeding decisions and therefore produce puppies which will not go blind as a result of this mutation."

Mike Townsend, Chairman of the Kennel Club Charitable Trust, said: "This is a real breakthrough and one which we hope will help to prevent blindness in many Golden Retrievers in the years to come. Every dog deserves to lead a healthy, happy life and it is important that we do all we can to ensure that future generations are given this opportunity. Our knowledge about inherited diseases in dogs is growing every day and the development of DNA tests such as this one allows breeders to ensure that the healthiest genes are passed down through the generations."

The DNA test for PRA follows the success of the AHT's DNA test launched last year to identify carriers of a mutation that causes primary lens luxation. This test identifies carriers in more than 12 breeds of dog, including Miniature Bull Terriers, Jack Russell Terriers, Parson Russell Terriers and Patterdale Terriers. To date more than 6,500 samples from 36 countries have been tested.

The Kennel Club Charitable Trust has committed £1.2 million to the Kennel Club Genetics Centre at the AHT, which will undertake research into approximately 25 inherited diseases over the next five years, facilitating the creation of further diagnostic tests which will improve the health and welfare of generations of dogs.

Full information on the Golden Retrievers PRA DNA test, and information on ordering sample kits, will be available from http://www.aht.org.uk/ from 15 November.

A new module has been added to Ceva Animal Health UK's Cardio Academy website entitled "Cardiac Drugs - Mechanism of Action" which discusses the mode of action for the main drugs used to treat cardiac disease in dogs.

The interactive module, which lasts around 30 minutes, is presented by leading cardiologist Clarke Atkins, professor of medicine and cardiology at North Carolina State University. 

A CPD certificate can be downloaded after completing a quiz at the end of the module.

To access the Cardio Academy visit http://www.cardioacademy.cevalearn.com/.

Environmental household flea spray, Acclaim^®, is now licensed to kill house dust mites. A common cause of allergies, house dust mites are present all year around, aggravating conditions such as atopic dermatitis.

Containing S-methoprene and permethrin, Acclaim is a fast-acting, odourless household spray which kills fleas and flea larvae and has 12 months' activity against flea egg development.  It also kills ants, cockroaches, ticks and spiders and does not break down in sunlight in the home.

For information on CEVA Animal Health's complete range of household flea treatments, which includes the traditional pesticide sprays Acclaim^® and Staykil^® and the innovative non-pesticide product Skoosh^®, please contact your local CEVA account manager.

Genitrix has taken on the exclusive UK distribution of the Oxbow Professional range of premium recovery diets for herbivores and carnivores. 

The Oxbow range was developed in the USA, covers a wide range of exotic species, and is offered in multiple pack sizes to ensure ease of use and cost effectiveness. Key products within the range include Critical Care, Critical Care Fine Grind and new Carnivore Care.

Carnivore Care is a recovery diet for carnivores including cats, ferrets, raptors and snakes, which are unwilling or unable to eat their normal diet. Developed specifically for carnivorous mammals, reptiles and birds, it contains easily digestible proteins, as well as high taurine and L-carnitine in a powdered formula which is easy to mix.  It can be self fed, fed by syringe or even by tube to cats, ferrets, raptors, and other carnivorous small mammals and reptiles. It is used for conditions including malnutrition, severe weight loss, appetite stimulation, gastroenteritis, pre and post surgical care and as a medication carrier.

Critical Care is a recovery diet for herbivores, including rabbits, guinea pigs, hamsters, tortoises and other herbivorous mammals and reptiles. Formulated to contain all essential nutrients, as well as timothy hay to ensure proper gut physiology and digestion, it can be self fed or fed by syringe and is used in cases including gastrointestinal stasis, severe weight loss, dental disease/post extraction, for gastric hair balls and pre and post surgery

Critical Care Fine Grind is a recovery food which is particularly suitable in cases where tube feeding is required. Formulated to contain timothy hay and essential nutrients, it is offered in a fine particle size to ensure easy flow through nasogastric tubes and syringes. It can be used to feed herbivorous mammals and reptiles unwilling or unable to eat due to illness, surgery or poor nutritional status.

John Chitty BVetMed, CertZooMed, CBiol, MIBiol, MRCVS of the JC Exotic Pet Consultancy said:  "In my opinion, the Oxbow Professional Line is the best recovery diet range on the market as it gives vets a variety of high quality options for multiple species. It can make really make the difference in a successful recovery."

Howard Wilder, Genitrix' Managing Director, said: "We're focused on delivering innovative products for companion animals and exotic pets which advance veterinary care and provide revenue opportunities for veterinary practices.

"The Oxbow range covers a uniquely wide range of species giving vets a flexible 'one range fits all' recovery care diet for convalescing pets, which has been well researched and formulated. We're delighted to launch the Oxbow Professional range in the UK and believe many veterinary practices will find it a beneficial addition to their armoury."

he leaflet has been produced following changes in legislation concerning maternity, paternity and adoption, and covers issues such as:

• When employees need to tell their employer that they're pregnant, when maternity pay starts, all about paternity rights, and what to do when they're ready to return to work
• For employers, a timeline of when to do what, what to do when a locum tells them they're pregnant, and all about paternity and adoption rights
• Where locums stand on maternity, paternity and adoption

The leaflet includes timelines for quick reference together with health and safety advice, including a template risk assessment form.

Professor Bill Reilly, BVA past president, chaired the members services sub group which developed the document. He said: "This Guidance tells everyone in the practice team what they need to know about pregnancy in the workplace.

"Developed with the help of human resources and legal experts this Guidance answers common questions, gives a great overview of what should happen when, as well as who has which rights and responsibilities.

"It is specifically tailored to the veterinary environment so vets, vet nurses and practice managers should all find the clear advice useful."

BVA members can download the guide from www.bva.co.uk/guides.

A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.

Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.

The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany.  It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK.  The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.

The study concluded that:

• The testing of fenbendazole in a total of 80 yards showed resistance present in more than 80% of the UK and German yards and in 38% of Italian yards
• Pyrantel was tested in all 102 yards with resistance being found in 25% of yards in all three countries
• Resistance to ivermectin was significantly lower with resistance found in only one yard in Italy and two in the UK from a total of the 102 yards tested
• No resistance to moxidectin, the active ingredient of Equest and Equest Pramox, was detected in any yard in any country
• Multiple resistance to fenbendazole and pyrantel or ivermectin was identified in all 3 countries, with one yard in the UK found to have resistance to fenbendazole, pyrantel and ivermectin

According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.

He said:  "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."

Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals. 

 "We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."

Seven veterinary surgeons who took their final assessments at the University of Liverpool on 6 September have become the first to receive the postgraduate RCVS Certificate in Advanced Veterinary Practice with equine designations.

Dr Mark Holmes, a member of the RCVS sub-committee for the CertAVP who observed the assessments at Liverpool said: "I was very impressed by the quality of all the candidates and the diligence of the examination process.

"It is clear that candidates putting themselves forward for 'named' certificates have demonstrated particular interest in their chosen fields and place considerable value on passing their synoptic examination."

The modular certificates were introduced in 2007 to be a more flexible replacement for the old-style postgraduate certificates. Vets can now choose from 79 subject modules, with RCVS-accredited assessments offered by a range of universities. These institutions may also offer associated courses which vets can take to support their studies, although candidates are free to choose where and how they wish to study.

To build their credits into the full CertAVP qualification candidates must first enrol with the RCVS, which keeps a record of modules achieved.  Candidates need to take two compulsory modules, and several of a range of optional modules, within ten years in order to receive the award. Candidates aiming for a designated award must choose specific modules from amongst the options, and additionally pass an overarching 'synoptic' assessment.

For more information about the individual modules and the qualification as a whole, prospective candidates can visit www.rcvs.org.uk/modcerts.

Life Technologies has announced the launch of a new ELISA test for bluetongue virus (BTV) antibodies.

According to the company, studies have confirmed that the LSI VET Ruminant Bluetongue II-serum ELISA can detect antibodies to BTV in experimentally infected sheep after 6 days, and in cattle after 7-8 days - several days sooner than some other commercially available test kits, including the company's previous ELISA test which the new product has replaced.

Life Technologies asked the UK's Pirbright Institute, the European Union Reference Laboratory for BTV, to conduct a preliminary assessment of the new test. The new test was able to detect antibodies in all 24 BTV reference sera and BTV 26 held by Pirbright, and showed high sensitivity in a longitudinal study of experimentally infected animals.

The Pirbright study also demonstrated that the LSI VET Ruminant Bluetongue II-serum ELISA could detect BTV antibodies in cattle and sheep that had been vaccinated with an inactivated Bluetongue vaccine.

The new test was developed by Life Technologies Animal Health in its research laboratory near Lyon in France and will be available in EU countries via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.

The British Equine Veterinary Association's (BEVA) Equine Rescue Fund (ERF) has taken delivery of 'Howie the Rescue Horse', the UK's first lifesized model of a horse designed specially for training vets and firefighters

Howie will be used for the practical elements of the Rescue and Emergency Medicine Training for Equine Vets courses run by BEVA in partnership with Hampshire Fire and Rescue Service's animal rescue specialists. He will also be taken on the road to vet schools and be loaned to fire and rescue services wishing to train firefighters in manual emergency equine handling techniques.

Howie was designed to the animal rescue specialist's exacting specifications by Wales-based company Big Beasts, which more usually creates bespoke models, creatures, and props for the film and television industry, as well as for museums and theme parks.

Howie has been named after Genitrix' managing director, Howard Wilder after the company (which makes equine joint treatments such as irap HY-50®Vet) stepped in to cover the significant production costs of the model.

Howard said:  "Horse rescue is a complex and hazardous operation, both for the animal and those trying to rescue it and treat any injuries. As a company actively involved in equine care, we felt it was important to make a significant financial contribution to the Equine Rescue Fund.  It's great that Howie has safely arrived and we hope he'll prove an important asset to the ERF."

Picture shows:  Howie the Rescue Horse with (left to right) Howard Wilder and Buster Brown and Jim Green, Animal Rescue Specialists, Hampshire Fire and Rescue Service

The BVA has announced that from 2013, its annual Congress will take place at the London Vet Show.

The association says that the move is being done to bring together political debate and clinical CPD on a large scale and to ensure that the BVA can reach an even wider audience with its representative and educational services.

The BVA and the Vet Show teamed up last year at London Vet Show 2011 to announce the launch of the BVA Careers Fair, which will be hosted at this year's London Vet Show on 15-16 November, and the start of a partnership that would ensure discounted Vet Show rates for BVA members.

2013 will also see two new clinical streams added to the London Vet Show programme creating a comprehensive CPD event for vets in small and mixed practice. Cattle and equine streams for mixed practitioners will be delivered by the BVA to run alongside the popular companion animal stream provided by the Royal Veterinary College.

The partnership will also see substantial discounts being offered to BVA members.

BVA President Carl Padgett said: "BVA's number one value is that our members are at the heart of everything we do. We know that members require good value, high quality and relevant CPD and we believe that our new partnership with the London Vet Show offers the best opportunity for us to provide members with exactly what they want.

"It's a significant move for BVA but one that makes complete sense. From 2013 we will be bringing together the contentious issue streams that are the bedrock of BVA Congress, with a high quality clinical CPD programme covering large and small animals, and one of the biggest and best veterinary exhibitions.

"We know we haven't attracted the delegate numbers we would like to have done in recent years and by partnering with the London Vet Show we have the opportunity to reach a much greater audience. It's a very exciting step forward for BVA."

Rob Chapman, Event Director for the London Vet Show, said: "We are all delighted to be developing our relationship with the BVA. To be able to host such an established and prestigious event as the BVA Congress at the London Vet Show is an honour for the Vet Show.

"Combining the long-standing history of the BVA with the rapidly developing reputation of the Vet Show gives us a great symbiotic relationship. The new clinical content that we will be working on together will help the event and that relationship even further offering great value for both Vet Show delegates and BVA members."

The RCVS has announced what it calls 'minor updates' to the Practice Standards Scheme’s (PSS) modules for accreditations and awards.

The Practice Standards Scheme was launched in 2005 and then relaunched in 2015 to better recognise and reward how practices use their resources to create a positive outcome for patients and clients.

The modules and awards for all species groups (small animals, farm animal, and equine) have now been updated and a summary of the changes can be found at the end of each set of the respective modules.

Pam Mosedale, Lead Assessor, said: "These updates are part of our continuous efforts to ensure we have a flexible PSS, one that can respond to feedback and constantly reflect the realities of everyday practice.

"We would encourage all PSS-accredited practices to familiarise themselves with the updated modules, especially if they have an accreditation or awards assessment in the near future."

To view the updates, visit: http://www.rcvs.org.uk/practice-standards-scheme/ and download the appropriate 'related document' (v1.2)

The Disciplinary Committee of the Royal College of Veterinary Surgeons last week ordered a month's suspension for a veterinary surgeon from Dolgellau for dishonest certification of bovine tuberculin testing in the Gwynedd area in early 2007.

At a hearing that concluded last Friday, Iwan Parry, a partner of The Veterinary Surgery, Bala Road, Dolgellau, and an Official Veterinarian, was charged with serious professional misconduct for certifying on eight separate occasions that he had tested and inspected cattle for clinical signs of bovine tuberculosis (TB), when he had not done so. At the outset of the hearing, Mr Parry denied the charges.

The Committee heard that Animal Health (a DEFRA Executive Agency) had discovered irregularities in TB testing paperwork from Mr Parry's practice. These included two locum veterinary surgeons, who were not Local Veterinary Inspectors (LVIs), having carried out TB pre-movement testing, but the relevant paperwork being signed and certified by Mr Parry. It therefore suspended him from LVI duties and lodged a complaint with the RCVS.

The Committee heard that, at the time, Mr Parry's practice was in difficulty as all eight of his assistant veterinary surgeons had recently left and he was struggling to maintain services. It was also reported that the incidence of bovine TB in Mr Parry's area was very low.

Under questioning, Mr Parry admitted that he had not done the testing, but had allowed non-LVI veterinary surgeons to do so and then signed the certificates himself. Denying the charge of dishonesty, he maintained that he had thought his actions were legitimate, providing he questioned the veterinary surgeons afterwards and checked their results. However, he told the Committee he now deeply regretted this "honest mistake", made at a time of great personal pressure, and that it would not be repeated.

The Committee also heard evidence from a number of character witnesses, including Mr Elfyn Llwyd MP, testifying to Mr Parry's good character, integrity and good standing in the local community and agricultural sector.

Nevertheless, in view of Mr Parry's long experience as an LVI, his understanding of the importance of routine herd testing and accurate veterinary certification and his reputation for keeping up to date with legislative and professional developments, the Committee decided that his actions were not just inappropriate, but were the result of conscious impropriety on his part. It found that he was not only guilty of dishonesty, but of allowing non-LVIs to perform TB testing, both of which amounted to serious professional misconduct.

In passing judgment, the Committee emphasised that the integrity of veterinary certification was of the utmost importance, especially when carried out on behalf of the Government, in order to safeguard animal health and facilitate international trade. It also felt that Mr Parry could not have failed to have been fully aware of what he was signing and that he should not have done so.

It was, however, prepared to take account of some exceptional mitigating factors in this case, including the low risk of TB spread following Mr Parry's actions; that no financial gain had been sought or received by him; his unblemished career and uprightness of conduct to date; the esteem in which he was held in the farming community and the potential (financial) impact on that community if he were to be removed from the Register (therefore unable to practise) for a significant period of time.

Nigel Swayne MRCVS, chairing the Disciplinary Committee, concluded: "We are reminded that the primary purpose of any sanction is not punishment, but the maintenance of public confidence in the profession and to uphold professional standards of conduct.

"Whilst only a reprimand is not an appropriate sanction where dishonesty and false certification have been found proved, and such findings would normally attract at least a long period of suspension, given the wholly exceptional circumstances of this case and the strength of the mitigating factors, we direct that Mr Parry should be suspended for one month."